연구성과로 돌아가기
2023 연구자 정보 (63 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lee, Yunjoo (Lee, Y) |
Northwestern Mem Hosp, Dept Internal Med, Chicago, IL 60611 USA |
|
|
[JCR상위 1.7] Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation. [JCR상위 19.0] A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation [JCR상위 1.7] Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) |
SCIE | 1.7 |
ONCOLOGY SURGERY;TRANSPLANTATION |
ychae@nm.org; | ||
|
Lim, Tien Huey (Lim, TH) |
Pusan Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Yangsan, South Korea |
|
|
[JCR상위 1.7] Safety and efficacy of VIR-2218 with or without pegylated interferon alfa in virally-suppressed participants with chronic hepatitis B virus infection: post-treatment follow-up | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Lim, Woosung (Lim, W) |
|
|
[JCR상위 1.7] Prospective single-arm study of endocrine therapies with ovarian function suppression in premenopausal patients with node-positive early breast cancer with low genomic risk (INTERSTELLAR trial, KBCSG-25) [JCR상위 1.7] Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial) |
SCIE | 1.7 | ONCOLOGY | ||||
|
Macfarlane, Chelsea (Macfarlane, C) |
GSK, Waltham, MA USA |
|
|
[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; | ||
|
Mak, Lung-Yi (Mak, LY) |
제1저자 |
Sch Clin Med, Dept Med, Hong Kong, Peoples R China Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Peoples R China |
ABB-1599-2020 Mak, Lung Yi (Loey) |
0000-0002-2266-3935 Mak, Lung Yi |
[JCR상위 1.7] A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | |
|
Makowsky, Mallory (Makowsky, M) |
|
|
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) | SCIE | 1.7 | ONCOLOGY | ||||
|
Makris, Lukas (Makris, L) |
|
|
[JCR상위 1.7] Phase 2 study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (P) in advanced gastric or gastroesophageal junction (GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Mameda, Naresh (Mameda, N) |
Koneru Lakshmaiah Educ Fdn, Dept Chem, Guntur 522302, Andhra Pradesh, India Koneru Lakshmaiah Educ Fdn, Dept Engn Chem, Vaddeswaram 522302, Andhra Pradesh, India |
AAV-2711-2020 Mameda, Dr. Naresh |
0000-0002-0488-7521 Mameda, Naresh |
[JCR상위 1.7] Bifunctional S-scheme hybrid heterojunction comprising CdS nanorods and BiOIO 3 nanosheets for efficient solar-induced antibiotic degradation and highly-selective CO 2 reduction [JCR상위 44.1] Defective nano-silica loaded polymeric carbon nitride for visible light driven CO2 reduction and dye degradation |
SCIE | 1.7 |
MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING CHEMISTRY, PHYSICAL |
surendart@knu.ac.kr; vidyasagar.devtade@gmail.com;ssumare1965@gmail.com; |
||
|
Mao, Shenghua (Mao, SH) |
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med,Sch Med, Daegu, South Korea |
|
|
[JCR상위 1.7] Safety and efficacy of VIR-2218 with or without pegylated interferon alfa in virally-suppressed participants with chronic hepatitis B virus infection: post-treatment follow-up | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Mccoy, Carrie L. (Mccoy, CL) |
|
|
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) | SCIE | 1.7 | ONCOLOGY | ||||
|
McEwen, Robert (McEwen, R) |
|
|
[JCR상위 1.7] Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low, hormone receptor-positive (HR plus ) unresectable and/or metastatic breast cancer (mBC): Exploratory biomarker analysis of DESTINY-Breast04 | SCIE | 1.7 | ONCOLOGY | ||||
|
Miklos, David Bernard (Miklos, DB) |
제1저자 | 교신저자 | Stanford Univ, Sch Med, Stanford, CA 94305 USA |
|
0000-0003-0717-4305 Miklos, David |
[JCR상위 1.7] Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | SCIE | 1.7 | ONCOLOGY | dmiklos@stanford.edu; |
|
Mngqibisa, Rosie (Mngqibisa, R) |
Enhancing Care Fdn, Durban, South Africa |
JXM-3390-2024 Mngqibisa, Rosie |
|
[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; | ||
|
Mockbee, Colleen M. (Mockbee, CM) |
|
|
[JCR상위 1.7] Phase 2 study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (P) in advanced gastric or gastroesophageal junction (GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Mody, Kabir (Mody, K) |
|
|
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) | SCIE | 1.7 | ONCOLOGY |
페이지 이동: